20-960389-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001029871.4(RSPO4):āc.673G>Cā(p.Val225Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000228 in 1,538,308 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001029871.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RSPO4 | NM_001029871.4 | c.673G>C | p.Val225Leu | missense_variant | 5/5 | ENST00000217260.9 | |
RSPO4 | NM_001040007.3 | c.487G>C | p.Val163Leu | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RSPO4 | ENST00000217260.9 | c.673G>C | p.Val225Leu | missense_variant | 5/5 | 1 | NM_001029871.4 | P1 | |
RSPO4 | ENST00000400634.2 | c.487G>C | p.Val163Leu | missense_variant | 4/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000278 AC: 4AN: 143942Hom.: 0 AF XY: 0.0000519 AC XY: 4AN XY: 77132
GnomAD4 exome AF: 0.0000231 AC: 32AN: 1386138Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 16AN XY: 684160
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152170Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74328
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.673G>C (p.V225L) alteration is located in exon 5 (coding exon 5) of the RSPO4 gene. This alteration results from a G to C substitution at nucleotide position 673, causing the valine (V) at amino acid position 225 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at